Literature DB >> 20955294

Creation of a prevascularized site for cell transplantation in rats.

Philipp Stiegler1, Veronika Matzi, Eve Pierer, Oliver Hauser, Silvia Schaffellner, Heiko Renner, Joachim Greilberger, Reingard Aigner, Alfred Maier, Carolin Lackner, Florian Iberer, Freyja-Maria Smolle-Jüttner, Karlheinz Tscheliessnigg, Vanessa Stadlbauer.   

Abstract

INTRODUCTION: Transplanted cells, especially islet cells, are likely to become apoptotic due to local hypoxia leading to graft dysfunction. Isolated pancreatic islet cells depend on the diffusion of oxygen from the surrounding tissue; therefore, access to sufficient oxygen supply is beneficial, particularly when microcapsules are used for immunoisolation in xenotransplantation. The aim of this study was to create a prevascularized site for cell transplantation in rats and test its effectiveness with microencapsulated HEK293 cells.
METHODS: The combination of implantation of a foam dressing, vacuum-assisted wound closure (foam+VAC) and hyperbaric oxygenation (HBO) was used in 40 Sprague-Dawley rats. Blood flow and vascular endothelial growth factor (VEGF) levels were determined. Sodium cellulose sulphate (SCS)-microencapsulated HEK293 cells were xenotransplanted into the foam dressing in rats pre-treated with HBO, and angiogenesis and apoptosis were assessed.
RESULTS: Vessel ingrowth and VEGF levels increased depending on the duration of HBO treatment. The area containing the foam was perfused significantly better in the experimental groups when compared to controls. Only a small amount of apoptosis occurs in SCS-microencapsulated HEK293 cells after xenotransplantation.
CONCLUSION: As ischemia-damaged cells are likely to undergo cell death or loose functionality due to hypoxia, therefore leading to graft dysfunction, the combination foam+VAC and HBO might be a promising method to create a prevascularized site to achieve better results in xenogeneic cell transplantation.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20955294     DOI: 10.1111/j.1399-3089.2010.00606.x

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  7 in total

1.  Bioengineering a highly vascularized matrix for the ectopic transplantation of islets.

Authors:  Cara E Ellis; Branka Vulesevic; Erik Suuronen; Telford Yeung; Karen Seeberger; Gregory S Korbutt
Journal:  Islets       Date:  2013-11-21       Impact factor: 2.694

Review 2.  Alternative transplantation sites for pancreatic islet grafts.

Authors:  Elisa Cantarelli; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

Review 3.  Engineering biomimetic materials for islet transplantation.

Authors:  Ethan Y Yang; Joshua P Kronenfeld; Cherie L Stabler
Journal:  Curr Diabetes Rev       Date:  2015

4.  Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation.

Authors:  Preeti Chhabra; Kenneth L Brayman
Journal:  J Transplant       Date:  2011-10-20

5.  Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation.

Authors:  Cyrus Jahansouz; Cameron Jahansouz; Sean C Kumer; Kenneth L Brayman
Journal:  J Transplant       Date:  2011-10-15

6.  Alginate-Poly(ethylene glycol) Hybrid Microspheres for Primary Cell Microencapsulation.

Authors:  Redouan Mahou; Raphael P H Meier; Léo H Bühler; Christine Wandrey
Journal:  Materials (Basel)       Date:  2014-01-09       Impact factor: 3.623

7.  Effects of Different Pressure Levels in Topical Negative Pressure Application-Analysis of Perfusion Parameters in a Clinical Skin Model Using Multimodal Imaging Techniques.

Authors:  Emine Ceylan Aslan-Horch; Raymund E Horch; Andreas Arkudas; Wibke Müller-Seubert; Ingo Ludolph
Journal:  J Clin Med       Date:  2022-08-31       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.